A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction

Icosapent ethyl (IPE) was the first fish oil product the US Food and Drug Administration (FDA) approved to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in adults. IPE is an esterified version of eicosapentaenoic acid (EPA) and acts as a prodrug in the body to exert its effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Huston, Jessica, Schaffner, Hannah, Cox, Alyssa, Sperry, Alexander, Mcgee, Shelby, Lor, Payeng, Langley, Logan, Skrable, Blake, Ashchi, Majdi, Bisharat, Mohannad, Gore, Ashwini, Jones, Thomas, Sutton, David, Sheikh-Ali, Mae, Berner, Jason, Goldfaden, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184960/
https://www.ncbi.nlm.nih.gov/pubmed/37188993
http://dx.doi.org/10.1007/s40256-023-00583-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184960/
https://www.ncbi.nlm.nih.gov/pubmed/37188993
http://dx.doi.org/10.1007/s40256-023-00583-8

Ejemplares similares